Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI

E R Wisner1, E G Amparo, D R Vera

  • 1Department of Radiology, School of Medicine, University of California, Davis 95817.

Abstract

Insights

Particle size impacts arabinogalactan-coated superparamagnetic iron oxide (AG-SPIO) contrast enhancement in liver tumors. Larger AG-SPIO particles slightly improve enhancement but do not significantly affect lesion detection by CNR.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Radiology

Background:

  • Superparamagnetic iron oxide nanoparticles (SPIONs) are used as MRI contrast agents.
  • Arabinogalactan coating (AG-SPIO) influences nanoparticle properties.
  • Particle size is a critical factor in SPION performance.

Purpose of the Study:

  • To evaluate the effect of AG-SPIO particle size on MR contrast enhancement in liver tumors.
  • To determine if particle size influences hepatic lesion detection using CNR.

Main Methods:

  • T2*-weighted gradient-recalled echo MR imaging was performed on tumor-bearing rats.
  • Rats received intravenous AG-SPIO with small (15.7 nm), medium (49.1 nm), or large (86.9 nm) particle sizes.
  • Contrast-to-noise ratio (CNR) and percent contrast enhancement (PCE) were calculated.

Main Results:

  • All particle sizes significantly improved CNR post-administration (p < 0.001).
  • Larger AG-SPIO particles showed significantly higher PCE compared to smaller particles (p < 0.001).
  • No significant difference in postcontrast CNR was observed between different particle sizes.

Conclusions:

  • Larger AG-SPIO particles offer a slight improvement in liver contrast enhancement.
  • Particle size did not significantly impact hepatic lesion detection as measured by CNR.
  • Further research may explore optimal AG-SPIO characteristics for enhanced tumor imaging.